XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Sep 27, 2024 | (Q2)Jun 28, 2024 | (Q1)Mar 29, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 29, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 8.00%1.08B | 9.65%1.07B | 7.11%1.01B | 37.09%3.96B | 6.35%1.04B | 4.52%1B | 96.33%977.85M | 106.69%943.46M | 62.07%2.89B | 133.23%978.17M |
Operating revenue | 8.00%1.08B | 9.65%1.07B | 7.11%1.01B | 37.09%3.96B | 6.35%1.04B | 4.52%1B | 96.33%977.85M | 106.69%943.46M | 62.07%2.89B | 133.23%978.17M |
Cost of revenue | 6.38%990.22M | 12.12%998.35M | 8.75%940.29M | 39.77%3.63B | 9.30%942.36M | 8.10%930.83M | 96.44%890.45M | 106.22%864.63M | 59.92%2.6B | 122.19%862.19M |
Gross profit | 29.37%91.44M | -15.52%73.84M | -10.85%70.27M | 13.51%334.86M | -15.54%97.95M | -27.20%70.68M | 95.26%87.4M | 111.93%78.83M | 83.90%295.01M | 269.67%115.97M |
Operating expense | -16.30%41.55M | -12.65%46.41M | -17.22%39.94M | -12.04%210.44M | -30.05%59.42M | -46.39%49.64M | 78.65%53.13M | 50.98%48.25M | 143.13%239.24M | 297.78%84.95M |
Selling and administrative expenses | -16.30%41.55M | -12.65%46.41M | -17.22%39.94M | -12.04%210.44M | -30.05%59.42M | -46.39%49.64M | 78.65%53.13M | 50.98%48.25M | 143.13%239.24M | 297.78%84.95M |
Operating profit | 137.12%49.89M | -19.97%27.43M | -0.81%30.33M | 123.08%124.42M | 24.18%38.53M | 368.89%21.04M | 128.15%34.27M | 483.90%30.58M | -10.08%55.77M | 209.74%31.03M |
Net non-operating interest income expense | 10.25%-27.15M | 9.84%-28.81M | 13.14%-27.57M | -97.87%-122.44M | 7.99%-28.5M | -10.96%-30.25M | -1,527.61%-31.95M | -1,788.40%-31.74M | -674.94%-61.88M | -1,578.64%-30.97M |
Non-operating interest income | -44.01%187K | 111.35%298K | 39.42%290K | 485.45%966K | 185.86%283K | 1,987.50%334K | 2,250.00%141K | 383.72%208K | --165K | --99K |
Non-operating interest expense | -10.62%27.34M | -9.30%29.11M | -12.79%27.86M | 98.90%123.41M | -7.37%28.78M | 12.11%30.59M | 1,529.81%32.09M | 1,753.36%31.95M | 677.01%62.04M | 1,628.99%31.07M |
Other net income (expense) | -58.00%-3.2M | -2,064.95%-6.73M | 92.59%-1.63M | -26.49M | -2.11M | -2.02M | -311K | -22.05M | ||
Special income (charges) | --0 | ---2M | --0 | ---22.3M | ---246K | --0 | --0 | ---22.05M | --0 | --0 |
-Less:Other special charges | ---- | --2M | ---- | --22.3M | --246K | ---- | ---- | --22.05M | ---- | ---- |
Other non- operating income (expenses) | -58.00%-3.2M | -1,422.51%-4.74M | ---1.63M | ---4.19M | ---1.86M | ---2.02M | ---311K | ---- | ---- | ---- |
Income before tax | 273.86%19.54M | -503.88%-8.11M | 104.84%1.12M | -301.41%-24.52M | 14,055.36%7.93M | 50.67%-11.24M | -84.61%2.01M | -752.90%-23.22M | -111.30%-6.11M | -99.31%56K |
Income tax | 192.74%4.49M | -847.62%-1.57M | 99.65%-20K | -123.66%-1.95M | -21.13%8.42M | 15.72%-4.84M | -91.88%210K | -918.40%-5.74M | -1.02%8.22M | 1,460.67%10.68M |
Net income | 335.17%15.05M | -463.76%-6.54M | 106.54%1.14M | -57.52%-22.57M | 95.37%-492K | 62.44%-6.4M | -82.82%1.8M | -712.26%-17.48M | -131.34%-14.33M | -241.81%-10.62M |
Net income continuous Operations | 335.17%15.05M | -463.76%-6.54M | 106.54%1.14M | -57.52%-22.57M | 95.37%-492K | 62.44%-6.4M | -82.82%1.8M | -712.26%-17.48M | -131.34%-14.33M | -241.81%-10.62M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 335.17%15.05M | -463.76%-6.54M | 106.54%1.14M | -57.52%-22.57M | 95.37%-492K | 62.44%-6.4M | -82.82%1.8M | -712.26%-17.48M | -131.34%-14.33M | -241.81%-10.62M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 335.17%15.05M | -463.76%-6.54M | 106.54%1.14M | -57.52%-22.57M | 95.37%-492K | 62.44%-6.4M | -82.82%1.8M | -712.26%-17.48M | -131.34%-14.33M | -241.81%-10.62M |
Basic earnings per share | 328.57%0.48 | -450.00%-0.21 | 107.02%0.04 | -7.35%-0.73 | 95.74%-0.02 | 63.16%-0.21 | -93.26%0.06 | -337.50%-0.57 | -117.39%-0.68 | -173.44%-0.47 |
Diluted earnings per share | 323.81%0.47 | -450.00%-0.21 | 107.02%0.04 | -7.35%-0.73 | 95.74%-0.02 | 63.16%-0.21 | -93.18%0.06 | -337.50%-0.57 | -117.62%-0.68 | -179.66%-0.47 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |